同和药业 (300636.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(同和药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
单季度财务指标:
 单季度销售毛利率(%) 37.0040.0027.0030.0036.0041.0031.0025.0031.00
 单季度销售净利率(%) 21.0017.0012.0015.0015.0014.0017.0010.0015.00
 单季度净资产收益率ROE(%) 2.001.001.002.002.002.003.002.003.00
 单季度总资产净利率ROA(%) 1.001.001.001.001.001.002.001.001.00
单季度财务摘要:
 单季度营业总收入(元) 206,454,983.00162,476,836.00177,907,849.00161,007,542.00220,746,479.00191,633,459.00192,299,827.00156,203,725.00179,771,416.00
 单季度营业总成本(元) 150,662,134.00123,579,933.00149,783,635.00147,572,839.00178,963,288.00156,534,814.00157,952,934.00145,127,328.00149,238,775.00
 单季度营业收入(元) 206,454,983.00162,476,836.00177,907,849.00161,007,542.00220,746,479.00191,633,459.00192,299,827.00156,203,725.00179,771,416.00
 单季度营业利润(元) 49,031,954.0023,012,859.0028,085,922.0026,115,347.0035,018,130.0026,707,044.0034,414,082.0015,654,606.0029,556,664.00
 单季度利润总额(元) 48,965,204.0023,340,214.0028,085,922.0026,115,347.0034,958,865.0026,557,044.0034,414,082.0015,654,606.0029,523,928.00
 单季度净利润(元) 43,562,751.0027,330,089.0021,622,335.0023,934,358.0033,096,475.0026,181,115.0031,847,859.0015,810,170.0026,828,216.00
 单季度归属母公司股东的净利润(元) 43,562,751.0027,330,089.0021,622,335.0023,934,358.0033,096,475.0026,181,115.0031,847,859.0015,810,170.0026,828,216.00
 单季度经营活动产生的现金流量(元) 29,743,589.0058,019,395.00-19,346,291.0039,810,797.0085,264,632.0054,615,583.0030,890,854.0014,051,708.0096,438,593.00
 单季度投资活动产生的现金流量(元) -148,676,249.00-4,759,991.00-369,429,391.00-122,008,592.00-210,007,902.00-59,358,668.00-51,773,153.00-102,321,517.00-128,532,333.00
 单季度筹资活动产生的现金流量(元) 150,196,833.0071,198,874.00732,173,417.0072,733,549.0079,153,361.0010,376,939.005,693,111.00101,838,640.00-49,338,103.00
 单季度现金及现金等价物净增加(元) 32,817,601.00125,570,738.00344,877,451.00-8,453,495.00-47,370,255.003,652,285.00-13,979,559.0015,675,566.00-81,640,865.00

前瞻产业研究院